Safety Study of the VEGA UV-A System to Treat Keratoconus

NCT01190306 ↗

Phase 3 Terminated 127 enrolled Topcon Medical Systems, Inc.

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of corneal collagen cross-linking (CXL), when used to treat keratoconus.

Timeline

Start: 2010-08
Primary completion: 2011-12
Completion: 2011-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Background	Riboflavin	Other / unclassified	—	—

Safety Study of the VEGA UV-A System to Treat Keratoconus

Summary

Timeline

Drugs

Indications